CIBC Private Wealth Group’s Intellia Therapeutics NTLA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.8K | Sell |
4,025
-646
| -14% | -$6.06K | ﹤0.01% | 1771 |
|
|
2025
Q1 | $29.3K | Buy |
4,671
+60
| +1% | +$377 | ﹤0.01% | 1840 |
|
|
2024
Q4 | $55.4K | Sell |
4,611
-3,771
| -45% | -$45.3K | ﹤0.01% | 1648 |
|
|
2024
Q3 | $172K | Buy |
8,382
+2,502
| +43% | +$51.4K | ﹤0.01% | 1261 |
|
|
2024
Q2 | $135K | Buy |
5,880
+1,299
| +28% | +$29.8K | ﹤0.01% | 1277 |
|
|
2024
Q1 | $125K | Buy |
+4,581
| New | +$125K | ﹤0.01% | 1302 |
|
|
2022
Q4 | – | Sell |
-4,324
| Closed | -$242K | – | 916 |
|
|
2022
Q3 | $242K | Sell |
4,324
-2,500
| -37% | -$140K | ﹤0.01% | 824 |
|
|
2022
Q2 | $353K | Hold |
6,824
| – | – | ﹤0.01% | 770 |
|
|
2022
Q1 | $496K | Sell |
6,824
-223
| -3% | -$16.2K | ﹤0.01% | 746 |
|
|
2021
Q4 | $833K | Hold |
7,047
| – | – | ﹤0.01% | 681 |
|
|
2021
Q3 | $945K | Hold |
7,047
| – | – | ﹤0.01% | 633 |
|
|
2021
Q2 | $1.14M | Sell |
7,047
-4,008
| -36% | -$649K | ﹤0.01% | 634 |
|
|
2021
Q1 | $887K | Buy |
11,055
+4,650
| +73% | +$373K | ﹤0.01% | 691 |
|
|
2020
Q4 | $348K | Buy |
+6,405
| New | +$348K | ﹤0.01% | 842 |
|
|
2018
Q3 | – | Sell |
-3,020
| Closed | -$83K | – | 1458 |
|
|
2018
Q2 | $83K | Sell |
3,020
-869
| -22% | -$23.9K | ﹤0.01% | 1062 |
|
|
2018
Q1 | $82K | Buy |
3,889
+889
| +30% | +$18.7K | ﹤0.01% | 1054 |
|
|
2017
Q4 | $58K | Buy |
+3,000
| New | +$58K | ﹤0.01% | 1142 |
|